Scott Rolfs

Ziegler Investment Banking

Guest

Managing Director of Ziegler Investment Banking, specializing in religious properties

Scott Rolfs on KCRW

Televangelist Robert Schuller's  Chrystal Cathedral  is bankrupt, and Schuller's family runs a board of directors that recently changed its mind about selling the complex for $50…

Who'll Get the Crystal Cathedral?

Televangelist Robert Schuller's Chrystal Cathedral is bankrupt, and Schuller's family runs a board of directors that recently changed its mind about selling the complex for $50…

from Which Way, L.A.?

More from KCRW

With the narrow approval of Governor Gavin Newsom’s $6.4 billion mental health bond, Prop 1, the work begins to build thousands of treatment beds.

from KCRW Features

The Downtown LA gay bar Redline opened in 2015. Now it joins a long legacy of LGBTQ spaces that have closed in the city center.

from KCRW Features

Karen Bass talks about the efficacy of her signature Inside Safe program, preparing LA for the Olympics, and Measure HLA.

from Press Play with Madeleine Brand

Early results point to several run-off elections in Orange County, setting up competitive races for supervisors and congressional seats.

from KCRW Features

How should the media cover a Biden/Trump rematch? What mistakes did we see in coverage of the special counsel testimony? Should perception influence policy?

from Left, Right & Center

Katie Porter’s influence turned Orange County competitive, but after her Senate race loss, Democrats now face the challenge of keeping that same momentum going.

from KCRW Features

A committee wants to invest in the happiness of Californias with data-proven ideas. But a multi-billion dollar state budget deficit looms over their efforts.

from KCRW Features

Residents want a nearby landfill — where a chemical reaction is happening underneath — to shut down to preserve their health. Months later, it’s still operating.

from KCRW Features

Out-of-pocket costs for Paxlovid have shot up for Medicare patients, and programs to help get the COVID-alleviating drug for less aren’t well known.

from KCRW Features